Prof. Dr. Franz Schilling and Martin Grashei from the Technical University of Munich (@TUMuenchen1) in Germany, use Bruker preclinical instruments to develop novel magnetic resonance methods such as hyperpolarization, pulse sequence development, and novel imaging biomarkers.
Watch how the team at TUM is using a new molecular MRI agent for hyperpolarized 13C-labelled Z-OMPD.

Learn more on the Scilling Lab website: https://goto.bruker.com/3uiUzUH

To see our solutions for Preclinical MRI, please visit https://goto.bruker.com/42c6ock

#PreclinicalImaging #MRI #Imaging